Voyager Therapeutics, Inc.

Erste Asset Management GmbH VYGR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

1,195,141

Value ($000)

4,718

Weight

0.0%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	4,718	0.0%	1,195,141	12/31/2025
2025 Q3	11/12/2025	5,260	0.1%	1,116,793	9/30/2025
2025 Q2	8/14/2025	3,445	0.0%	1,116,793	6/30/2025
2025 Q1	5/14/2025	3,826	0.0%	1,116,793	3/31/2025
2024 Q4	2/10/2025	5,945	0.1%	1,058,378	12/31/2024
2024 Q3	11/14/2024	6,192	0.1%	1,058,378	9/30/2024
2024 Q2	11/26/2024	8,362	0.1%	1,058,378	6/30/2024
2024 Q1	11/26/2024	9,901	0.1%	1,058,378	3/31/2024
2023 Q4	11/26/2024	9,003	0.1%	1,058,378	12/31/2023
2023 Q3	11/26/2024	8,197	0.1%	1,058,378	9/30/2023
2023 Q2	11/26/2024	12,117	0.2%	1,058,378	6/30/2023
2023 Q1	11/26/2024	8,393	0.2%	1,088,378	3/31/2023
2022 Q4	11/26/2024	6,859	0.1%	1,138,378	12/31/2022
2022 Q3	11/26/2024	6,756	0.2%	1,138,378	9/30/2022
2022 Q2	11/26/2024	6,733	0.1%	1,138,378	6/30/2022
2022 Q1	11/25/2024	9,356	0.2%	1,222,900	3/31/2022
2021 Q4	11/25/2024	3,590	0.1%	1,262,900	12/31/2021
2021 Q3	11/25/2024	2,549	0.1%	962,900	9/30/2021
2021 Q2	11/25/2024	3,070	0.1%	742,900	6/30/2021
2021 Q1	11/25/2024	2,805	0.1%	592,900	3/31/2021
2020 Q4	11/25/2024	2,816	0.1%	387,900	12/31/2020
2020 Q3	11/25/2024	3,683	0.1%	342,900	9/30/2020
2020 Q2	11/22/2024	4,303	0.2%	342,900	6/30/2020
2020 Q1	11/22/2024	3,032	0.2%	333,900	3/31/2020
2019 Q4	11/22/2024	4,334	0.2%	320,900	12/31/2019
2019 Q3	11/22/2024	5,256	0.3%	305,900	9/30/2019
2019 Q2	11/22/2024	8,082	0.4%	298,900	6/30/2019
2019 Q1	11/22/2024	5,712	0.3%	298,900	3/31/2019
2018 Q4	11/26/2024	529	0.0%	58,900	12/31/2018